Not Yet Recruiting PHASE4 INTERVENTIONAL 2-arm
NCT07332910
Study the Anti-inflammatory Effect of Tranexamic Acid When Used in Anterior Cruciate Ligament Reconstruction. (TXA)
Tranexaminc Acid : Single Dose vs Placebo to Modulate Postoperative Inflammation After ACL Reconstruction : A Prospective, Randomized, Double-blind Trial
Sponsor: Centre Hospitalier Universitaire Brugmann
Conditions
ACL Reconstruction Hemarthrosis
Interventions
Placebo (NaCl 0,9%) Tranexamic Acid (TXA)
Updated 1 time since 2026 Last updated: Dec 31, 2025 Started: Jan 20, 2026 Primary completion: Jun 1, 2026 Completion: Jun 1, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE4 clinical study on ACL Reconstruction and Hemarthrosis, this trial is actively recruiting participants. The trial is conducted by Centre Hospitalier Universitaire Brugmann and has accumulated 1 data snapshot since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Centre Hospitalier Universitaire Brugmann
- Chirec
- Erasme University Hospital
Data source: Chirec
For direct contact, visit the study record on ClinicalTrials.gov .